文献速递妇科生殖医学

盆底肌物理治疗对深部浸润型子宫内膜异位症患者肛提肌裂孔面积的影响:随机对照试验

Assessment of levator hiatal area using 3D/4D transperineal ultrasound in women with deep infiltrating endometriosis and superficial dyspareunia treated with pelvic floor muscle physiotherapy: randomized controlled trial.
PubMed 文献 · Ultrasound Obstet Gynecol · 2021-01-01

本研究为随机对照试验,纳入34例深部浸润型子宫内膜异位症伴浅表性交痛的未产女性,随机分为盆底肌物理治疗组(17例)和无干预对照组(17例)。主要结局为最大Valsalva动作时肛提肌裂孔面积(LHA)的百分比变化,治疗组显著高于对照组(20.0 ± 24.8% vs -0.5 ± 3.3%;P = 0.02)。治疗组浅表性交痛NRS评分中位变化为-3(IQR -4至-2),对照组为0(IQR 0-0),组间差异显著(P < 0.01)。

要点

  • 盆底肌物理治疗可增加Valsalva动作时肛提肌裂孔面积,提示盆底肌松弛改善。
  • 盆底肌物理治疗显著降低浅表性交痛NRS评分(中位变化-3 vs 0)。
  • 盆底肌物理治疗对慢性盆腔痛也有改善趋势(P = 0.01)。

核心结论

  • 在深部浸润型子宫内膜异位症女性中,盆底肌物理治疗可能增加Valsalva动作时肛提肌裂孔面积,并改善浅表性交痛、慢性盆腔痛及盆底肌松弛。

研究设计与样本

  • 随机对照试验,纳入34例深部浸润型子宫内膜异位症伴浅表性交痛的未产女性,1:1随机分为盆底肌物理治疗组(17例)和无干预对照组(17例)。
  • 盆底肌物理治疗组接受5次个体化治疗,首次检查后4个月进行第二次评估。

主要发现

  • 最大Valsalva动作时LHA百分比变化:治疗组20.0 ± 24.8%,对照组-0.5 ± 3.3%,组间比较P = 0.02。
  • 浅表性交痛NRS评分中位变化:治疗组-3(IQR -4至-2),对照组0(IQR 0-0),P < 0.01。
  • 慢性盆腔痛NRS评分中位变化:治疗组0(IQR -2至0),对照组0(IQR 0-1),P = 0.01。

关键数值与推荐

  • 主要结局为最大Valsalva动作时LHA从基线至随访的百分比变化。
  • 疼痛症状采用数值评定量表(NRS)评估,包括浅表性交痛、深部性交痛、痛经、慢性盆腔痛、排尿困难和排便困难。

临床怎么用

  • 对于深部浸润型子宫内膜异位症伴浅表性交痛的患者,可考虑盆底肌物理治疗以改善盆底肌松弛和疼痛症状。
  • 三维/四维经会阴超声可用于评估盆底肌物理治疗前后肛提肌裂孔面积的变化。

局限性

  • 原文未报告盲法、分配隐藏及长期随访结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Deep infiltrating endometriosis (DIE) is associated with chronic pelvic pain, dyspareunia and pelvic floor muscle hypertonia. The primary aim of this study was to evaluate the effect of pelvic floor physiotherapy (PFP) on the area of levator ani hiatus during Valsalva maneuver, assessed using transperineal ultrasound, in women with DIE suffering from superficial dyspareunia. METHODS: This was a randomized controlled trial of 34 nulliparous women diagnosed with DIE and associated superficial dyspareunia. After an initial clinical examination, all patients underwent three-dimensional/four-dimensional (3D/4D) transperineal ultrasound to measure the levator hiatal area (LHA) at rest, on maximum pelvic floor muscle contraction and on maximum Valsalva maneuver, and were asked to rate their pain symptoms using a numerical rating scale (NRS). Eligible women were assigned randomly (1:1 ratio) to no intervention (control group, 17 women) or treatment with five individual sessions of PFP (study group, 17 women). Four months after the first examination, all women underwent a second evaluation of pain symptoms and LHA on transperineal ultrasound. The primary outcome measure was the percentage change in LHA on maximum Valsalva maneuver between the baseline and follow-up examinations. The percentage changes in pain symptoms between the two examinations, including superficial and deep dyspareunia, dysmenorrhea, chronic pelvic pain, dysuria and dyschezia, were also evaluated. RESULTS: Thirty women, comprising 17 in the study group and 13 in the control group, completed the study and were included in the analysis. The percentage change in LHA on maximum Valsalva maneuver between the two examinations was higher in the study group than in the control group (20.0 ± 24.8% vs -0.5 ± 3.3%; P = 0.02), indicating better pelvic floor muscle relaxation. After PFP treatment, the NRS score for superficial dyspareunia remained almost unchanged in the control group (median change in NRS (Δ-NRS), 0 (interquartile range (IQR), 0-0)) while a marked reduction was observed in the study group (median Δ-NRS, -3 (IQR, -4 to -2); P < 0.01). Moreover, there was a significant difference between the PFP and control groups with regards to the change in chronic pelvic pain (median Δ-NRS, 0 (IQR, -2 to 0) vs 0 (IQR, 0-1); P = 0.01). CONCLUSIONS: In women with DIE, PFP seems to result in increased LHA on Valsalva maneuver, as observed by 3D/4D transperineal ultrasound, leading to improved superficial dyspareunia, chronic pelvic pain and pelvic floor muscle relaxation. © 2020 International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Del Forno S, Arena A, Pellizzone V, et al. Assessment of levator hiatal area using 3D/4D transperineal ultrasound in women with deep infiltrating endometriosis and superficial dyspareunia treated with pelvic floor muscle physiotherapy: randomized controlled trial. Ultrasound Obstet Gynecol. 2021. PMID: 33428320. doi:10.1002/uog.23590

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。